Business Development

As a leading biopharma company, partnering is a key priority for us and plays a critical role in our strategy. We seek to combine external innovative science and technologies with our internal capabilities and expertise to transform patients’ lives through science. Partnerships and collaborations are essential to evolving our portfolio and driving our long-term sustainability.

Partnering to speed transformational medicines to patients

Working together to transform patients' lives through science.

Partnering to speed transformational medicines to patients

12/20 of our blockbuster drugs are derived from collaborations
60% of development pipeline are externally sourced.
300+ active alliances.

Working together

We have a distinct and decisive approach to partnering that leverages the best of Bristol Myers Squibb and the best of our partners to speed transformational medicines to patients.  We strive to be a partner of choice and establish a creative and customized approach for each agreement. 

Why partner with us

Why partner with us

Our partnerships

Our partnerships

Begin discussion

Begin discussion

Our areas of interest

External innovation and partnering are critical drivers of our strategy and have brought significant commercial success and pipeline growth.

our area of interest

Business Development leadership team Learn more

Giovanni Caforio, M.D., Chairman and CEO, Bristol-Myers Squibb
   

"We are open to a wide range of partnership opportunities focused on transformational science and we are committed to being a leading biopharma partner."

 

Elizabeth Mily, Executive Vice President Strategy and Business Development